Abstract
Calf thymosin was injected s.c. in daily doses of 0.1-3 mg for 12-15 days into adult thymectomized, irradiated, bone marrow-reconstituted (THXB) mice. Thymosin partially restored the ability of the T [thymus-derived] cell-depleted host to develop delayed-type hypersensitivity to sheep erythrocytes. The degree of restoration varied from 50-75% of control values. Thymosin treatment of normal mice potentiated the footpad responsiveness to sheep erythrocytes by as much as 50% over that of untreated controls. The optimum dosage of thymosin seemed to be in the 200-500 .mu.g range, and multiple injections were essential for a significant response. Twelve daily injections of 100-500 .mu.g of thymosin restored T-cell reactivity to the THXB mouse, but the responsiveness decayed relatively rapidly once the treatment was stopped. The restoration of immune responsiveness to sheep erythrocytes in T-cell depleted mice provides a convenient means of demonstrating activity in thymosin preparations in vivo.